See the following AlzForum article, including comments at the bottom from independent researchers.
Finally: Big Win on All Outcomes for Lecanemab in Phase 3 Topline Results:
Another good-news story - this time for A... - Cure Parkinson's
Another good-news story - this time for Alzheimer's disease - Lecanemab (an anti-amyloid antibody) achieves some success in a Phase 3 trial
Written by
jeffreyn
To view profiles and participate in discussions please or .
1 Reply
•
Yes, the big question for us is does this mean the amyloid theory bears weight? (So would removing the Alpha synuclein for PD have therpudic benefits also). Maybe there's hope!
Not what you're looking for?
You may also like...
Annovis Bio Announces Approval for EU Clinical Trial Sites for the Phase 3 Study of Buntanetap for the Treatment of Parkinson's Disease
significant results in Phase 2 with this drug for Parkinson's Disease and this is a large Phase 3...
Phase 3 Positive Topline Results for Tavapadon
data from the trial will be presented at a future medical meeting; results from the tavapadon Phase...
KARMET Study Begins Enrollment
altering afferent neural signaling from gut to brain. Based on results from the RASMET study,...
ADVICE ON CPAP MACHINE RESULTS
machine, and the results after just over three weeks have me somewhat baffled as follows. Of the...
More Success With Rats. Yawn.
neurodegenerative diseases, including Alzheimer’s and Parkinson’s disease, researchers say.\\"...
Can we trust clinical studies?
Good news from Annovis (for Alzheimer's)
ACTIVE-ASSISTED CYCLING improves tremor and bradykinesia in Parkinson's disease.
Lactobacillus Plantarum PS128
